Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities
Net income (loss)	$ 32,252	$ (13,981)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation expense	17,280	398
Depreciation and amortization expense	15	8
Changes in operating assets and liabilities:
Accounts receivable	(50,000)
Prepaid expenses and other current assets	2,895	(2,409)
Other assets	(293)
Accounts payable	16,456	2,643
Accrued expenses and other liabilities	23,586	1,035
Deferred revenue	(76,376)
Net cash used in operating activities	(34,185)	(12,306)
Cash flows from investing activities
Additions to property and equipment		(6)
Net cash used in investing activities		(6)
Cash flows from financing activities
Proceeds from issuance of convertible preferred stock, net of issuance costs		106,631
Proceeds from issuance of common stock for exercise of stock options	528	27
Payments made for initial public offering costs		(215)
Net cash provided by financing activities	528	106,443
Net increase (decrease) in cash, cash equivalents and restricted cash	(33,657)	94,131
Cash, cash equivalents and restricted cash at the beginning of period	850,224	21,768
Cash, cash equivalents and restricted cash at the end of period	816,567	115,899
Cash, cash equivalents and restricted cash at the end of period:
Cash and cash equivalents	816,460	115,792
Restricted cash	107	107
Cash, cash equivalents and restricted cash at the end of period	$ 816,567	115,899
Supplemental disclosure of noncash financing activities
Equity issuance costs included in accounts payable and accrued expenses		$ 919